# Implementing the STAMPP-HTN bundle in a high-risk Mississippi population

> **NIH NIH P20** · UNIVERSITY OF MISSISSIPPI MED CTR · 2020 · $264,382

## Abstract

Hypertension during pregnancy, such as preeclampsia, is an important cause of maternal, fetal
and neonatal death in the U.S. Women who suffer hypertension in pregnancy are at increased
risk of complications during pregnancy as well as post-delivery. The risk of complications
arising from hypertension during and after pregnancy disproportionally affects black women,
who are much higher risk of morbidity and mortality from preeclampsia compared to white
women. We will implement the Systematic Treatment and Management of Postpartum
Hypertension (STAMPP-HTN) bundle to women who have recently completed a hypertensive
pregnancy. This includes home blood pressure telemonitoring (HBPT) a combination of home
blood pressure monitoring coupled with telematic data transmission to a member of the study
team, with real-time feedback on patient status and guideline-based postpartum discharge
instructions. These ACOG guidelines include education on the importance of blood pressure
control and postpartum preeclampsia. We hypothesize that the addition of HBPT to an
improved guideline-based hospital discharge will result in improved BP control resulting in less
maternal morbidities and improved attendance to the 6-week postpartum visit. To test this
central hypothesis, we have developed the following objectives:
Objective 1) To determine if HBPT decreases the severity of postpartum hypertension
complications we will compare postpartum outcomes (trips to the emergency room, phone
calls regarding blood pressure, hospital readmission, severity of any new comorbidities,
maternal deaths) between women being monitored to those from the previous year who
received no postpartum blood pressure monitoring.
Objective 2) To increase awareness and knowledge of postpartum blood pressure control in a
group of high-risk women we will administer a 9-question survey before any hypertension
education is conducted with study participants and again at the end of the 6-week study.
Objective 3) To assess compliance using HBPT and adherence to blood pressure medication (if
applicable) in high-risk postpartum women study completion records (per week) will be
compared with study covariates (i.e. maternal race, age, parity).

## Key facts

- **NIH application ID:** 10154086
- **Project number:** 3P20GM121334-04S1
- **Recipient organization:** UNIVERSITY OF MISSISSIPPI MED CTR
- **Principal Investigator:** Jane F Reckelhoff
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $264,382
- **Award type:** 3
- **Project period:** 2017-06-08 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10154086

## Citation

> US National Institutes of Health, RePORTER application 10154086, Implementing the STAMPP-HTN bundle in a high-risk Mississippi population (3P20GM121334-04S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10154086. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*